Please login to the form below

Tesaro

This page shows the latest Tesaro news and features for those working in and with pharma, biotech and healthcare.

GSK acquired Jemperli as part of its $5.1bn acquisition of cancer specialist Tesaro, although the drug was initially developed by AnaptysBio.

GSK wins approval for anti-PD-1 antibody Jemperli in endometrial cancer

GSK acquired Jemperli as part of its $5.1bn acquisition of cancer specialist Tesaro, although the drug was initially developed by AnaptysBio.
GSK’s PD-1 inhibitor dostarlimab shows updated promise in dMMR solid tumours

GSK gained dostarlimab from its $5.1bn acquisition of cancer specialist Tesaro, as well as PARP inhibitor Zejula (niraparib), which is approved across a number of indications including ovarian, fallopian tube
GlaxoSmithKline reportedly looking to sell select antibiotic brands

Since the beginning of 2019, GSK and new CEO Walmsley have been trying to reverse that deal, with a high profile takeover of cancer specialist firm Tesaro at the end of ... As a result of the Tesaro deal, GSK gained the rights to PARP inhibitor treatment
GSK pays $50m upfront to tap Immatics’ cell therapy platform

GSK took full ownership of the therapy in 2018. GSK’s push into cancer has also included its $5.1bn acquisition of Tesaro, which brought in PARP inhibitor Zejula (niraparib).
Clovis leapfrogs PARP rivals, filing Rubraca for prostate cancer

J&J has exclusive rights to Zejula in prostate cancer under the terms of an agreement signed with the drug’s develop Tesaro ahead of its $5.1bn acquisition by GSK

More from news
Approximately 9 fully matching, plus 49 partially matching documents found.

Pharma funding and M&A in 2020

Indeed, in 2018 we saw GSK’s buy-out of Novartis’ stake in their consumer health joint venture for $13bn, as well as acquiring Tesaro for $5bn.
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe

Jacob Plieth at Vantage recently highlighted this trend, with companies like Tesaro, Clovis Oncology and Acadia failing to meet revenue expectations for their new launches.
Deal Watch January 2018

Licence. 339. TeneoBio/TESARO. Multi-specific antibodies for up to six undisclosed oncology targets using UniRat platform and discovery engine TeneoSeek.
Deal Watch February 2017

There has been speculation for several months that oncology company Tesaro may be the target for a large pharma bid and as a result its share price has increased by 570%
Deal Watch April 2016

Apart from the 3 deals by Abbvie, there were deals by GSK and Janssen with Zymeworks and Tesaro respectively. ... 500. Tesaro (US). Janssen (US). License and collaboration. Niraparib PARP inhibitor in clinical phase for treatment of prostate cancer.

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Ipsen hires general manager, Laura Hamill joins Gilead and Orchard expands leadership team

He joins the specialist pharmaceutical company from Tesaro, where he served as acting vice president and general manager for the UK, Ireland and Nordics.
Rubius Therapeutics strengthens senior team

Prior to GSK, Dr Carpenter was at Merck, where he led the development of Tesaro’s Zejula.
Adaptimmune appoints Lawrence Alleva to its board

He currently serves as a director for public companies Tesaro and Bright Horizons Family Solutions, and for the privately-held Mirna Therapeutics, and chairs those companies' audit committees.

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Market Access Director, six figure base salary and £5K joining b...: Highly competitive salary

Account Manager, 6 month contract, Healthcare Brand communicatio...: Highly competitive salary

Home Based Account Manager, Medical Communications, UK, Pharma/M...: Highly competitive salary

Account Director, Healthcare Marketing Creative Agency, Fixed te...: Highly competitive salary

Senior Medical Copywriter - Highly Awarded Advertising Agency: £50,000 - £60,000 yearly

Account Manager, Healthcare Marketing Creative Agency, Fixed ter...: Highly competitive salary

Add my company

Medscape Medical Affairs enables all medical affairs professionals to take a more strategic leadership role, and maximize the impact of...

Patient Clinical Trial & Communications Plan Review: A Customer Story: ...
Working together to achieve better patient pathways: Digital tools can supercharge patient treatment and outcomes but the importance of the patient voice cannot be underestimated...
Design-thinking. Iterating for continuous improvement.: How design can lead improvement within Pharma...

Email:
Password: